BioCrude Technologies USA, Inc. Stock-Based Compensation
BioCrude Technologies USA, Inc. reported Stock-Based Compensation of $0 for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2020-11-10
- BioCrude Technologies USA, Inc. share-based payment arrangement, noncash expense for the quarter ending 2018-09-30 was $12.00K.
- BioCrude Technologies USA, Inc. share-based payment arrangement, noncash expense for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- BioCrude Technologies USA, Inc. share-based payment arrangement, noncash expense for the quarter ending 2018-03-31 was $657.01K, a 15873.96% increase year-over-year.
- BioCrude Technologies USA, Inc. share-based payment arrangement, noncash expense for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- BioCrude Technologies USA, Inc. share-based payment arrangement, noncash expense for fiscal 2017 was $197.58K, a 713.15% increase from fiscal 2016.
- BioCrude Technologies USA, Inc. share-based payment arrangement, noncash expense for fiscal 2016 was $24.30K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|---|
| 2020-09-30 | $0.00 10-Q · filed 2020-11-10 | |||||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-10 | |||||
| 2018-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $12.00K derived: sum of 2 quarters · filed 2019-11-13 | $669.01K 10-Q · filed 2019-11-13 | $669.01K derived: sum of 4 quarters · filed 2019-11-13 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-24 | $657.01K 10-Q · filed 2018-08-24 | $657.01K derived: sum of 3 quarters · filed 2018-11-02 | $657.01K derived: sum of 4 quarters · filed 2018-11-08 | ||
| 2018-03-31 | $657.01K 10-Q · filed 2018-05-16 | $657.01K derived: sum of 2 quarters · filed 2018-11-02 | $657.01K derived: sum of 3 quarters · filed 2018-11-08 | $850.48K derived: sum of 4 quarters · filed 2018-11-08 | ||
| 2017-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-11-02 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | $193.47K derived: sum of 3 quarters · filed 2018-11-08 | $197.58K 10-K/A · filed 2018-11-02 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $193.47K derived: sum of 2 quarters · filed 2018-11-08 | $197.58K 10-Q · filed 2018-11-08 | $161.94K 10-Q · filed 2017-10-24 | $199.50K derived: sum of 4 quarters · filed 2018-11-08 | |
| 2017-06-30 | $193.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-24 | $197.58K 10-Q · filed 2018-08-24 | $4.11K 10-Q · filed 2017-09-12 | $199.50K derived: sum of 3 quarters · filed 2018-11-02 | $199.50K derived: sum of 4 quarters · filed 2018-11-02 | |
| 2017-03-31 | $4.11K 10-Q · filed 2018-05-16 | $6.04K derived: sum of 2 quarters · filed 2018-11-02 | $6.04K derived: sum of 3 quarters · filed 2018-11-02 | |||
| 2016-12-31 | $1.93K derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-11-02 | $1.93K derived: sum of 2 quarters · filed 2018-11-02 | $24.30K 10-K/A · filed 2018-11-02 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-24 | $22.37K 10-Q · filed 2017-10-24 | ||||
| 2016-06-30 | $22.37K 10-Q · filed 2017-09-12 |